INTRODUCTION AND OBJECTIVES: Assessment of surgical risk is integral to patient counseling and shared clinical decisionmaking. The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) surgical risk calculator is an easily accessible, online tool for predicting surgical outcomes after a variety of procedures. Little is known of the tool's applicability to urologic surgery. We sought to evaluate the predictive value of the calculator in a tertiary referral cohort of patients undergoing robot-assisted partial nephrectomy (RAPN).
METHODS: We queried our prospectively maintained multiinstitutional database of RAPN (n¼1260) from 2008 to 2016. Preoperative details of 300 randomly selected patients were entered into the calculator. The predicted rates of complications were compared with the actual rates of observed complications. Validation of the calculator was assessed by receiver-operator area under the curve (AUC) for discrimination and Brier score (BS) for calibration. Calculated BS was also compared to a null model (null-BS); a BS lower than the null model indicates stronger predictive power for that individual outcome where a BS of zero indicates perfect prediction.
RESULTS: The observed rate of any complication in our cohort was 14%, comparable with that reported in the literature, while the mean predicted rate of any complication was 5.42%. The calculated AUC for any complications was 0.51. Our cohort demonstrated a serious complication (Clavien Score 3) rate of 3.67%, lower than the predicted rate of 4.89% (AUC 0.55). The majority of the captured complications had a low BS, indicative of good calibration. However, the calculated AUC was low for all outcomes, indicating poor discrimination ability. Venous thromboembolism (VTE) and readmission had the highest AUCs -0.67 and 0.69, respectively. CONCLUSIONS: The ACS-NSQIP risk calculator poorly predicted most complications after RAPN. The model had marginal accuracy for predicting VTE and readmissions, and good accuracy for predicting the rate of serious complications, but it lacked the power to discriminate which patients were at risk to have such outcomes. These findings suggest the need for a more tailored outcome prediction model to accurately assist surgeons in counseling patients undergoing RAPN.
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MP76-08 THE IMPACT OF PATHOLOGICAL RISK FACTORS AND THE MANAGEMENT OF STAGE I NON SEMINOMATOUS GERM CELL TESTICULAR CANCER
Mazen Alsinnawi*, Seattle, WA; Sydney Akapame, seattle, WA; John Burns, John Paul Flores, Christopher Porter, Seattle, WA INTRODUCTION AND OBJECTIVES: The preferred method of management for analytic stage I (CS1) Non Seminomatous Germ Cell Tumors (NSGCT) is active surveillance (AS). Approximately 30% of men with CS1 NSGCT are liable to relapse on AS. Pathological risk factors (PRF) may identify men at higher risk for relapse. Our aim was to evaluate trends in managing CS1 NSGCT and to examine the influence of PRF.
METHODS: We used national cancer database (NCDB), 2004 to 2013; we examined AS, adjuvant Chemotherapy (ACT) and adjuvant retroperitoneal lymph node dissection (RPLND) using cross tabulation and trend analysis. We assessed PRF including, lympho-vascular invasion (LVI) and the presence of embryonal carcinoma (EC). We further examined the impact of CS1 sub-staging, IA, IB and IS, as defined by the TNM classification (UICC 2009 7th Ed.). Differences in overall survival (OS) were observed by treatment modality, based on log rank test.
RESULTS: 12,211 men were classified as CS1 NSGCT in NCDB; of these 2,484 men were LVI +ve, 4,686 were LVI -ve (5041 had missing LVI data); 2,624 men had EC. Trend analyses (Fig.1) showed a stable utilization of AS (p ¼ 0.310), a rising preference for ACT (p <0.001) and a declining utilization of RPLND (p <0.001). Analysis of PRF showed 40% of LVI +ve men had ACT vs 18% of LVI -ve men, Fig  2. The presence of EC increased the chances for ACT (32% vs 22% in those with no EC). Analysis of CS1 sub-staging showed 37% of IB and 29% of IS had ACT vs only 15% of IA sub-group. RPLND use was not influenced by sub-staging or LVI status.
CONCLUSIONS: AS remains underutilized in CS1 NSGCT. We observed a slow but steady rise towards more ACT usage and a declining utilization of RPLND. Utilization of ACT was greatly influenced by PRF. We believe that PRF and subgrouping of CS1 may be influencing decision making for men with CS1 NSGCT disease that is amenable to AS. Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE METHODS: Utilizing the NCDB, 44,354 patients were identified with data available for metastatic disease at time of diagnosis and tumor histology. Metastases were stratified as either absent, lymph node only, lung, brain, liver or bone metastases. Demographic characteristics, socioeconomic indicators and tumor histology were compared using the chi-squared test. Univariate survival analysis was performed using the Kaplan Meier method. Multivariate survival analysis was performed using cox proportional hazard model. RESULTS: Mean age of diagnosis was 35 and mean follow-up was 53 months. On univariate analysis decreased age at diagnosis (p<0.001), non-white race (p¼0.002), uninsured status (p¼<0.001), <$38,000 annual income (p¼<0.001), distance from treating hospital (p<0.001), and pure choriocarcinoma histology (166/202, 82%, p<0.001) were associated with metastases at time of diagnosis. 3,504 (7.9%) patients had metastatic disease at diagnosis. Kaplan Meier survival analysis showed significant differences in OS between metastatic sites at presentation, with 5 yr OS of 87% for lymph node only metastases compared to 48% OS in those with brain metastases (p<0.001). On multivariate analysis while controlling for age, race, insurance status, income, comorbidities, histology, receipt of chemotherapy, and primary tumor size, metastases to any site were associated with worsened survival compared to no metastases (referent): metastasis to lymph nodes (3.4, 95% CI: 2.70-4.50, p<0.001), lung (4.48, 95% CI: 3.69-5.43, p<0.001), liver (10.32, 95% CI: 6.78-15.7), bone (12.99, 95% CI: 7.93-21.29) and brain (14.4, 95% CI: 9.53-21.89). Private insurance status (0.48, 95% CI: 0.40-0.56, p<0.001) and income >$63,000 (0.72, 95% CI: 0.60-0.87, p¼0.001) were favorable predictors of OS.
CONCLUSIONS: There are significant differences in OS dependent on site of metastases at time of testicular cancer diagnosis. Several sociodemographic factors likely contribute to likelihood of metastases at presentation as well. Further prospective studies are warranted to better characterize the impact of sociodemographic factors on metastases at presentation and to improve access to care in high-risk populations. INTRODUCTION AND OBJECTIVES: Physician burnout is linked to decreased job performance as well as increased medical errors, interpersonal conflicts and depression. Two recent multi-specialty studies showed that compared to other physicians in the 29-65 age group, urologists had the highest rate of burnout (54.4% vs. 63.6%); however, these reports were limited by a low sample size for urologists (n¼119). We aimed to establish the prevalence of urologist burnout and to determine factors associated with burnout more comprehensively.
Source of
METHODS: In the 2016 AUA Census, Maslach Burnout Inventory (MBI) questions were randomly assigned to half of the respondents. Using matrix sampling, the 1,126 practicing urologists who received and answered the MBI questions represent the entire 2,301 who completed the Census with a sampling weight of 2.04. Burnout was defined as scoring high in either the emotional exhaustion (score27) or depersonalization (score10) categories. Demographic and practice variables were assessed through both univariate descriptive analysis and multivariate logistic analysis to establish correlating factors to burnout.
RESULTS: Overall, 38.8% of urologists met the criteria for burnout, of whom 17.2% scored high for emotional exhaustion and 37.1% scored high for depersonalization. Multivariate analysis revealed that urologist burnout is associated with a variety of factors as follows (ranked from most important): greater number of patient visits in a typical week; younger age group; in sub-specialty area other than pediatric or oncology; in either solo or multi-specialty practices; practice size of more than 2; and greater number of work hours in a typical week. (See table.) CONCLUSIONS: These results suggest that the burnout rate for urologists, 38.8% overall or 41.3% in urologists ages 29-65, is lower e1016 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 
